DAX24.042 -1,4%Est505.743 -0,8%MSCI World4.343 -0,1%Top 10 Crypto12,99 -4,7%Nas22.870 -2,3%Bitcoin84.724 -3,3%Euro1,1633 +0,3%Öl62,99 +0,5%Gold4.178 -0,5%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Siemens 723610 DroneShield A2DMAA NVIDIA 918422 Deutsche Telekom 555750 Rheinmetall 703000 RENK RENK73 Infineon 623100 Bayer BAY001 Highland Critical Minerals A4193E Novo Nordisk A3EU6F Tesla A1CX3T Volkswagen (VW) vz. 766403 Mercedes-Benz Group (ex Daimler) 710000 RWE 703712 HENSOLDT HAG000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-Shutdown beendet: DAX schließt schwächer -- Wall Street letztlich tiefrot -- Siemens mit Rekordgewinn -- RENK, Rheinmetall, HENSOLDT, Merck, NEL, Palantir, Deutsche Telekom, DroneShield im Fokus
Top News
Sieg im Bietergefecht: Pfizer schließt die Übernahme von Metsera ab - Aktie wenig verändert Sieg im Bietergefecht: Pfizer schließt die Übernahme von Metsera ab - Aktie wenig verändert
D-Wave Quantum-Aktie: Kurseinbruch nach schwachen Zahlen - Analysten bleiben dennoch optimistisch D-Wave Quantum-Aktie: Kurseinbruch nach schwachen Zahlen - Analysten bleiben dennoch optimistisch
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Indivior Aktie

Kaufen
Verkaufen
Indivior Aktien-Sparplan
24,80 EUR -0,40 EUR -1,59 %
FSE
29,95 USD +0,13 USD +0,44 %
nachbörslich
BTT
Indivior jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.3,34 Mrd. EUR

KGV828,67Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA3DWFC

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINGB00BN4HT335

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolINDV

Indivior Aktien News

DatumMeistgelesen
PR NewswireThe Gross Law Firm Notifies Shareholders of Indivior PLC(INDV) of a Class Action Lawsuit and an Upcoming Deadline
PR NewswireRosen Law Firm Urges Indivior PLC (INDV) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Indivior PLC of Class Action Lawsuit and Upcoming Deadlines - INDV
PR NewswireIndivior Announces BARDA's First Order of OPVEE® to Combat Opioids and Aid in National Preparedness
PR NewswireINDV LAWSUIT ALERT: Levi & Korsinsky Notifies Indivior PLC Investors of a Class Action Lawsuit and Upcoming Deadline
PR NewswireINDV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Indivior PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
PR NewswireINDV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Indivior PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Indivior PLC of Class Action Lawsuit and Upcoming Deadlines - INDV
PR NewswirePomerantz Law Firm Announces the Filing of a Class Action Against Indivior PLC and Certain Officers - INDV
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Indivior PLC - INDV
PR NewswireIndivior Announces a New $100 Million Share Repurchase Program; New Program will be Executed Over an Accelerated Time Frame
PR NewswireIndivior Announces Q2 2024 Financial Results
PR NewswireIndivior Announces Q2 2024 Financial Results
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Indivior PLC - INDV
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Indivior PLC - INDV
PR NewswireIndivior Provides Business Update; Conference Call at 8:00 AM U.S. EDT
PR NewswireIndivior Provides Business Update; Conference Call at 8:00 AM U.S. EDT
PR NewswireIndivior Announces the Publication of New Data on the Comparative Effectiveness of Intranasal (IN) Nalmefene (OPVEE 2.7mg) and IN Naloxone (4 mg) in a Translational Model Assessing the Impact of a...
PR NewswireIndivior Announces Dosing of First Subject with INDV-2000 in a Phase 2 Study Assessing the Safety and Efficacy of INDV-2000 in Individuals with Opioid Use Disorder
PR NewswireIndivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance
PR NewswireIndivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance
PR NewswireIndivior Announces Q1 2024 Financial Results
PR NewswireIndivior Announces Q1 2024 Financial Results
PR NewswireIndivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone
PR NewswireIndivior Announces Q4 / FY 2023 Financial Results
PR NewswireIndivior Announces Q4 / FY 2023 Financial Results
PR NewswireIndivior Announces Q3 2023 Financial Results
PR NewswireIndivior Announces Q3 2023 Financial Results
PR NewswireIndivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals
PR NewswireIndivior Publishes Real World Data Showing SUBLOCADE® May Reduce Non-Fatal Overdoses Among Individuals with Opioid Use Disorder in Canada
PR NewswireIndivior Announces Q2/H1 2023 Financial Results
PR NewswireIndivior Announces Q2/H1 2023 Financial Results

Indivior News

Indivior News: auf dieser Seite finden Sie alle Indivior News und Nachrichten zur Indivior Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Indivior News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Indivior News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.